The Food and Drug Administration rejected a bid from Elon Musk's human brain chips startup Neuralink to start human trials, according to Reuters.

Share:
More In Science
The Dark Side of Our Succulent Obsession
With an increased global appetite for rare, endangered species of cacti and succulents, many fear that one day, we won’t see many unique cacti in the wild anymore.
Load More